List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 50 studies with search of: "Kidney Biopsy"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy?
Conditions: Kidney Failure, Acute;   Kidney Failure, Chronic;   Blood Platelet Disorders;   Hemorrhage
Intervention: Device: measuring PFA-100 platelet function before kidney biopsy
2 Enrolling by invitation Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal
Condition: Kidney Transplantation
Interventions: Procedure: Kidney Biopsy;   Drug: Rapamune (sirolimus/rapamycin);   Drug: Tacrolimus
3 Active, not recruiting Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy
Condition: Diabetes, Type I
Interventions: Drug: Candesartan;   Drug: Placebo
4 Recruiting Genomics of Chronic Renal Allograft Rejection (The GoCAR Study)
Condition: Kidney Transplantation
Interventions: Procedure: Kidney biopsy;   Procedure: Blood collection
5 Completed A Study on a New Staining Method (C4d Staining) of Transplanted Kidney Biopsies
Conditions: Kidney Transplantation;   Graft Rejection
Intervention: Procedure: Renal biopsy
6 Recruiting 1-Deamino 8-d-Arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-Guided Renal Biopsy
Condition: Kidney Failure
Interventions: Drug: DDAVP;   Drug: placebo
7 Completed Prediction of Acute Rejection in Renal Transplant
Condition: Kidney Transplant
Intervention:
8 Active, not recruiting Renoprotection in Early Diabetic Nephropathy in Pima Indians
Condition: Diabetic Nephropathy
Intervention: Drug: Losartan
9 Recruiting Evaluation of Albuminuria HIV-Infected Patients
Conditions: HIV-Associated Focal Segmental Glomerulosclerosis;   HIV-Associated Collapsing Glomerulopathy;   Proteinuria;   Albuminuria;   Renal Tubular Toxicity
Intervention:
10 Active, not recruiting HSP-Glomerulonephritis Trial: MP vs CyA
Condition: Purpura, Schoenlein-Henoch
Intervention: Drug: MP pulses+prednisone or Cyclosporine A
11 Recruiting Retinoids for Minimal Change Disease and Focal Segmental Glomerulosclerosis
Conditions: Kidney Diseases;   Glomerulosclerosis, Focal
Interventions: Procedure: Kidney needle biopsy;   Procedure: DEXA Scan;   Procedure: X-rays;   Drug: Retinoids for Podocyte Disease
12 Recruiting Cause of Focal Segmental Glomerulosclerosis
Conditions: AIDS Associated Nephropathy;   Focal Glomerulosclerosis;   HIV Infections
Intervention:
13 Recruiting MMF vs. AZA for Kidney Transplantation
Condition: Kidney Transplant
Interventions: Drug: mycophenolate mofetil;   Drug: azathioprine
14 Enrolling by invitation Improved Induction and Maintenance Immunosuppression in Kidney Transplantation
Conditions: End-Stage Renal Disease;   Renal Transplantation
Interventions: Drug: rabbit anti-thymocyte globulin (rATG);   Drug: mycophenolate mofetil;   Drug: rabbit anti-thymocyte globulin;   Procedure: kidney transplantation;   Drug: sirolimus;   Drug: tacrolimus
15 Recruiting Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With No Steroids
Condition: Kidney Diseases
Intervention: Drug: Sirolimus
16 Recruiting Steroid Withdrawal in Pediatric Renal Transplant Immunosuppression : Impact on Growth, Bone Metabolism and Acute Rejection
Condition: Kidney Diseases
Interventions: Drug: Tacrolimus (TAC)+ Mycophenolate Mofetil (MMF) + Withdrawal Prednisone;   Drug: Tacrolimus (TAC)+ Mycophenolate Mofetil (MMF) + prednisolone
17 Completed The Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ Transplantation
Condition: Kidney Transplantation
Intervention:
18 Recruiting Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Conditions: Nephrotic Syndrome;   Proteinuria;   Autoimmune Disease;   Glomerular Disease;   Membranous Glomerulonephritis
Interventions: Drug: Rituximab Infusion;   Drug: Oral Cyclosporine
19 Recruiting Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease
Condition: Fabry Disease
Interventions: Drug: migalastat hydrochloride;   Drug: Placebo
20 Active, not recruiting Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
Conditions: Kidney Transplantation;   Kidney Disease;   Kidney Failure
Interventions: Drug: Alemtuzumab;   Drug: Mycophenolate mofetil;   Drug: Sirolimus;   Drug: Tacrolimus;   Procedure: Donor bone marrow stem cell infusion;   Procedure: Kidney transplant

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services